Latest news with #HeartInstitute
CTV News
11 hours ago
- Health
- CTV News
How a churro-inspired device could change bypass surgery
How a churro-inspired device could change bypass surgery A researcher from University of Ottawa Heart Institute took inspiration from a food truck when he was thinking of ways to make bypass surgery safer.
Yahoo
09-06-2025
- Health
- Yahoo
Dr. Jeffrey Towbin Announces Retirement from Le Bonheur Children's Hospital
MEMPHIS, Tenn., June 9, 2025 /PRNewswire/ -- After 40 years of practice as a pediatric cardiologist, Dr. Jeffrey Towbin will retire from Le Bonheur Children's Hospital and the University of Tennessee Health Science Center (UTHSC) on June 30, 2025. In addition to being Chief of Pediatric Cardiology, Executive Co-Director of the Heart Institute, and Vice Chair of Pediatrics for Strategy Advancement, Towbin's career has had a clinical focus on cardiomyopathy, heart failure and heart transplantation and a research focus on the genetics responsible for the development and progression of cardiac muscle disease, the causes and progression of arrhythmias and animal models with genetic abnormalities in cardiac muscle disease and arrhythmias. In the past 23 years, Dr. Towbin led three different Divisions of Pediatric Cardiology, including the Heart Center at Texas Children's Hospital/Baylor College of Medicine, the Heart Institute at Cincinnati Children's Hospital and the Heart Institute at Le Bonheur / UT Health Science Center, with each of these programs attaining top three to 10 U.S. News and World Report (USNWR) rankings. Dr. Towbin's leadership has led to the immense growth of Le Bonheur's Heart Institute and its programs, including the recruitment of over 40 top-tier cardiologists, the development of nationally recognized subspecialty programs, a cardiac advanced practice provider program and the creation of a Heart Institute expansion, including creation of a 31-bed Cardiovascular Intensive Care Unit (CVICU) and a state-of-the-art Cardiac MRI/Cath Lab suite. During his 10-year tenure at Le Bonheur, he led the Heart Institute to a top 10 ranking by U.S. News & World Report, recognition by the Pediatric Heart Transplant Society as a Vanguard Center of Excellence and recognition by the Hypertrophic Cardiomyopathy Association (HCMA) and Children's Cardiomyopathy Foundation (CCF) as a Recognized Center of Excellence. He was also the first recipient of the Bob and Paula McEniry Endowed Chair of Cardiology at Le Bonheur and was also the recipient of the St. Jude Endowed Chair of Pediatric Cardiology and Cardiac Research. Dr. Towbin developed the Heart Failure and Heart Transplant Program at Le Bonheur, created the first Molecular Cardiology Laboratories at UT Health Science Center and developed the Cardiovascular Genetics Program at Le Bonheur and the Cardio-Oncology Program at St. Jude Children's Research Hospital. Academically, Dr. Towbin had over 600 peer-reviewed publications, the highest impact factors within UT Health Science Center, held many National Institutes of Health (NIH) grants over his career and received many local, national and international awards. The awards include but are not limited to the 2025 American College of Cardiology (ACC) Lifetime Achievement Award, the 2024 Distinguished Heart Hero Award from the American Heart Association (AHA) Centennial Celebration, the 2023 American Academy of Pediatrics Section on Cardiology and Cardiac Surgery (AAP-SOCCS) Helen B. Taussig Founder's Award, the 2022 Stanford University's List of the World's Top 2% Scientists, the 2017 Distinguished Scientist of the AHA Award, the 2013 AHA Basic Research Prize, the 2007 ACC Distinguished Scientist (Basic Science) Award, the 1993 Young Investigator Award at the AAP-SOCCS and the 1991 Richard D. Rowe Perinatal Cardiology Research Award from the Society for Pediatric Research (SPR). From a teaching and mentoring perspective, Dr. Towbin has mentored more than 40 fellows and faculty members that have become Chiefs of Pediatric Cardiology, Department Chairs of Pediatrics and Deans of Medical Schools. Further, Dr. Towbin has been an invited speaker at countless national and international conferences and many guest professorships. Further, Dr. Towbin is a Fellow of multiple organizations including the American Academy of Pediatrics (FAAP), the American College of Cardiology (FACC), the American Heart Association (AHA), and the Heart Failure Society of America (FHFSA). About Le Bonheur Children'sLe Bonheur Children's, based in Memphis, Tenn., provides expert care for children in more than 45 pediatric subspecialties, encompassing robust community programs, a pediatric research institute and regional outpatient centers in Jackson, Tenn., Tupelo, Miss., and Jonesboro, Ark. Le Bonheur also features a 290-bed hospital in Memphis and a 21-bed satellite hospital within Jackson-Madison County General Hospital in Jackson, Tenn. As the primary pediatric teaching affiliate for the University of Tennessee Health Science Center, Le Bonheur trains more than 350 pediatricians and specialists each year. Nationally recognized, Le Bonheur has been named a U.S. News & World Report Best Children's Hospital for 14 consecutive years and is a Magnet-designated facility, the ultimate credential for high-quality patient care and nursing excellence. For more information, please call (901) 287-6030 or visit Connect with us at or on Instagram at lebonheurchildrens. Contact:David View original content to download multimedia: SOURCE Le Bonheur Children's Hospital
Al-Ahram Weekly
24-03-2025
- Health
- Al-Ahram Weekly
National Heart Institute implements successful innovative valve implantation techniques
The Minister of Health announced on its official website on Sunday that the National Heart Institute performed four successful pulmonary valve implantations using the MYVAL valve at a cost of one million Egyptian pounds per operation. Dr. Mohamed Mostafa Abdel Ghaffar, Chairman of the General Authority for Hospitals and Educational Institutes, stated that transcatheter pulmonary valve implantation (TPV) is a modern technique that represents a safe alternative to open-heart surgery. The new valve is inserted via a catheter without the need for a chest incision or cardiac arrest, significantly reducing risks and complications. He added that this technique reduces recovery time, allowing patients to leave the hospital within 24 to 48 hours. It also avoids surgical risks, such as severe bleeding, infection, and long recovery periods, improving life quality for patients who require valve replacement after previous heart surgeries. Dr. Mohamed Abdel Hadi, Director of the National Heart Institute, emphasized that the institute adopts the latest technologies to treat heart patients using the best available medical methods. A distinguished medical team headed by Dr Rania Diaa El-Din Abu Shoka, Head of the Congenital Catheterization Unit at the Heart Institute, and team members Dr Ahmed El-Sherbiny, Dr Mai Mohamed Saber, Dr Ahmed Alaa Hamed, and the Heart Institute's catheterization team stand behind the achievement. International expert Dr Shivakumar collaborated fruitfully with the team on the operations through his valuable scientific and technical contributions, which helped achieve these impressive results. The Institute's Director sincerely thanked everyone who contributed to the success of these delicate medical interventions, most notably the "Loyalty to Egypt" Foundation, which covered the full cost of valves for four patients during the month of Ramadan at a cost of approximately one million Egyptian pounds per patient. Follow us on: Facebook Instagram Whatsapp Short link:
Al-Ahram Weekly
23-03-2025
- Health
- Al-Ahram Weekly
National Heart institute implements innovative successful valve implantation techniques
On it official site today, Ministry of Health announced the success of the National Heart Institute in performing four pulmonary valve implantations using the MYVAL valve, at a cost of one million Egyptian pounds per operation. Dr. Mohamed Mostafa Abdel Ghaffar, Chairman of the General Authority for Hospitals and Educational Institutes, stated that transcatheter pulmonary valve implantation (TPV) is a modern technique that represents a safe alternative to open-heart surgery. The new valve is inserted via a catheter without the need for a chest incision or cardiac arrest, significantly reducing risks and complications. He added that this technique reduces recovery time, allowing patients to leave the hospital within just 24 to 48 hours. It also avoids surgical risks, such as severe bleeding, infection, and long recovery periods, improving the quality of life for patients who require valve replacement after previous heart surgeries. Dr. Mohamed Abdel Hadi, Director of the National Heart Institute, emphasized that the Institute adopts the latest technologies to treat heart patients using the best available medical methods. This medical achievement was achieved by a distinguished medical team under the leadership of Dr. Rania Diaa El-Din Abu Shoka, Head of the Congenital Catheterization Unit at the Heart Institute, and with the participation of team members Dr. Ahmed El-Sherbiny, Dr. Mai Mohamed Saber, Dr. Ahmed Alaa Hamed, and the Heart Institute's catheterization operations also witnessed fruitful collaboration with international expert Dr. Shivakumar, who made valuable scientific and technical contributions that helped achieve these impressive results. The Director of the Institute expressed his sincere thanks and appreciation to everyone who contributed to the success of these delicate medical interventions, most notably the "Loyalty to Egypt" Foundation for its continued support of these operations by covering the full cost of valves for four patients during the month of Ramadan, at a cost of approximately one million Egyptian pounds per patient. Follow us on: Facebook Instagram Whatsapp Short link:
Al-Ahram Weekly
23-03-2025
- Health
- Al-Ahram Weekly
Emad ..2...---National Heart institute implements innovative successful valve implantation techniques
On it official site today, Ministry of Health announced the success of the National Heart Institute in performing four pulmonary valve implantations using the MYVAL valve, at a cost of one million Egyptian pounds per operation. Dr. Mohamed Mostafa Abdel Ghaffar, Chairman of the General Authority for Hospitals and Educational Institutes, stated that transcatheter pulmonary valve implantation (TPV) is a modern technique that represents a safe alternative to open-heart surgery. The new valve is inserted via a catheter without the need for a chest incision or cardiac arrest, significantly reducing risks and complications. He added that this technique reduces recovery time, allowing patients to leave the hospital within just 24 to 48 hours. It also avoids surgical risks, such as severe bleeding, infection, and long recovery periods, improving the quality of life for patients who require valve replacement after previous heart surgeries. Dr. Mohamed Abdel Hadi, Director of the National Heart Institute, emphasized that the Institute adopts the latest technologies to treat heart patients using the best available medical methods. This medical achievement was achieved by a distinguished medical team under the leadership of Dr. Rania Diaa El-Din Abu Shoka, Head of the Congenital Catheterization Unit at the Heart Institute, and with the participation of team members Dr. Ahmed El-Sherbiny, Dr. Mai Mohamed Saber, Dr. Ahmed Alaa Hamed, and the Heart Institute's catheterization operations also witnessed fruitful collaboration with international expert Dr. Shivakumar, who made valuable scientific and technical contributions that helped achieve these impressive results. The Director of the Institute expressed his sincere thanks and appreciation to everyone who contributed to the success of these delicate medical interventions, most notably the "Loyalty to Egypt" Foundation for its continued support of these operations by covering the full cost of valves for four patients during the month of Ramadan, at a cost of approximately one million Egyptian pounds per patient. Follow us on: Facebook Instagram Whatsapp Short link:
